Showing results (2511-2520 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|August 15, 2013
Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cellsPhilipp Saiko, Geraldine Graser, Benedikt Giessrigl, et al.
Investigational New Drugs|January 16, 2016
Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenibSadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, et al.
Investigational New Drugs|December 22, 2015
A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)Joanne W Chiu, Sebastien J Hotte, Christian K Kollmannsberger, et al.
Investigational New Drugs|November 20, 2015
Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo studyJin Sun Yoon, Deok Won Hwang, Eun Shil Kim, et al.
Investigational New Drugs|April 1, 1989
Cellular pharmacology of fluorinated pyrimidines in vivo in manJ S Kovach, R W Beart
Investigational New Drugs|April 1, 1989
Design of some nucleic acid antimetabolites: expectations and realityJ P Horwitz
Investigational New Drugs|December 9, 2015
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II studyDidier Meulendijks, Laurens V Beerepoot, Henk Boot, et al.
Investigational New Drugs|September 26, 2015
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatinJhanelle E Gray, Jeffrey R Infante, Les H Brail, et al.
Investigational New Drugs|October 11, 2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L Swiecicki, Lili Zhao, Emily Belile, et al.
Investigational New Drugs|September 13, 2015
Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancerR van der Noll, W M Smit, A N M Wymenga, et al.
Pageof 372